Loading Events

This workshop will review how decisions you make in initial proof of concept and first-in-human trials can have long term impact on your product’s development. Thinking early about this impact can give statistical, regulatory, commercial, and competitive advantages for your product.

Dr. Isabel Elaine Allen
Senior Advisor, Bay View Analytics
Professor of Epidemiology & Biostatistics, UCSF
Faculty, Global Brain Health Institute, UCSF & Trinity College, Dublin

Dr. Allen collaborates in research in applied statistics including clinical and basic science, and teaches multivariate statistics, analytics & data visualization, and meta-analysis at the University of California, San Francisco (UCSF). Dr. Allen earned her doctorate in Statistics from Cornell University and is a fellow of the American Statistical Association. At UCSF, she has been named Consultant of the Year for multiple years. With Dr. Jeff Seaman, Babson Survey Research Group (now Bay View Analytics) received the Alfred P. Sloan Director’s Award for outstanding research in online education. In 2020, her research on discrimination by real estate agents, in collaboration with NY Newsday, received a Peabody Award, and the Edward R. Murrow Award for investigative journalism.

Dr. Julia Seaman
Research Director, Bay View Analytics

Dr. Seaman earned her doctorate in Pharmaceutical Chemistry and Pharmacogenomics from the University of California, San Francisco (UCSF). After completing her PhD, she moved into healthcare consulting, working with leading biotechnology companies as a strategy and competitive intelligence partner for four years before transitioning to Director of Research at Bay View Analytics. She currently concentrates on statistical and survey analysis project in scientific and educational research.

Feel free to share!

Go to Top